Super excited for tomorrow's ER Guidance Call for our first ever FDA approved commercialized product, Briumvi!

$TGTX Good TG week, nice to see the trend continue since approval. 😎🙏😎

They're FDA approved, have the best in class treatment, and is more affordable than the others.

Best drug approval of 2022.

Freshly approved drug and undervalued would mean the JP conference should be ideal for us.

$AUPH regardless of where the market goes 2023 will be a very good year for $AUPH and $TGTX Both having best in class block buster potential drugs approved

$TGTX successfully on time launch in Q1 2023 and EU approval mid year, we will be back to highs.

$TGTX is up 13% continued momentum following MS drug approvals.

$HTGM is over 100% since yesterday, looks for a good entry $KERN had a lot of volume yesterday $1.5 can be a good entry $VYNE announce split has been approved by board and can be executed at any time

Plus it is expecting more positive catalysts in weeks and months: 5 year data for breast cancer, Canada approval, China commercialziation, and much more.

FDA approved.

$KALA is the one up 500% on Phase 2 results where FDA approval of any possible kind is many years away and where the company is burning through $80 million per year for zero results.

$CTMX $KALA the next big runner after approval tomorrow wow! !

$KALA FDA approved!

Successful development and potential approval for KPI-012 will be a huge boost for the company.